The effects of piracetam on heroin-induced CPP and neuronal apoptosis in rats

Drug and Alcohol Dependence

Volumn 150, Issue , 2015, Pages 141-146

  Xu, Peng ^a,b   Li, Min ^a   Bai, Yanping ^b   Lu, Wei ^a   Ling, Xiaomei ^a   Li, Weidong ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b INSTITUTE OF FORENSIC SCIENCE   (China)

Author keywords

Corticolimbic system; CPP; Electron microscope; Heroin mixture; Piracetam; EP

Indexed keywords

BETA ENDORPHIN; DIAMORPHINE; PIRACETAM; NOOTROPIC AGENT;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BASOLATERAL AMYGDALA; CELL STRUCTURE; CHINA; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CYTOPLASM; ELECTRON MICROSCOPY; GOLGI COMPLEX; HEROIN DEPENDENCE; HIPPOCAMPAL CA1 REGION; LIMBIC SYSTEM; MALE; NEUROCHEMISTRY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; NUCLEUS ACCUMBENS; PLACE PREFERENCE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; REWARD; VENTROMEDIAL PREFRONTAL CORTEX; ANIMAL; DRUG EFFECTS; INSTRUMENTAL CONDITIONING; LEARNING; METABOLISM; NERVE CELL; PREFRONTAL CORTEX; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; APOPTOSIS; ASSOCIATION LEARNING; BETA-ENDORPHIN; CHINA; CONDITIONING, OPERANT; HEROIN; MALE; NEURONS; NOOTROPIC AGENTS; NUCLEUS ACCUMBENS; PIRACETAM; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; REWARD;

EID: 84926420701     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2015.02.026     Document Type: Article

References (37)

1. Ahmed A.H., Oswald R.E. Piracetam defines a new binding site for allosteric modulators of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors. J. Med. Chem. 2010, 53:2197-2203.
2. Ankarcrona M., Dypbukt J.M., Bonfoco E., Zhivotovsky B., Orrenius S., Lipton S.A., Nicotera P. Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 1995, 15:961-973.
3. Bardo M., Rowlett J., Harris M. Conditioned place preference using opiate and stimulant drugs: a meta-analysis. Neurosci. Biobehav. Rev. 1995, 19:39-51.
4. Bardo M.T., Bevins R.A. Conditioned place preference: what does it add to our preclinical understanding of drug reward?. Psychopharmacology 2000, 153:31-43.
5. Brandao F., Paula-Barbosa M.M., Cadete-Leite A. Piracetam impedes hippocampal neuronal loss during withdrawal after chronic alcohol intake. Alcohol 1995, 12:279-288.
6. Chiang C.Y., Cherng C.G., Lai Y.T., Fan H.Y., Chuang J.Y., Kao G.S., Chang W.T., Yu L. Medial prefrontal cortex and nucleus accumbens core are involved in retrieval of the methamphetamine-associated memory. Behav. Brain Res. 2009, 197:24-30.
7. Cunha-Oliveira T., Rego A.C., Garrido J., Borges F., Macedo T., Oliveira C.R. Street heroin induces mitochondrial dysfunction and apoptosis in rat cortical neurons. J. Neurochem. 2007, 101:543-554.
8. Gartry C.C., Oviedo-Joekes E., Laliberte N., Schechter M.T. NAOMI: the trials and tribulations of implementing a heroin assisted treatment study in North America. Harm Reduct. J. 2009, 6:2.
9. Ghafur M.S., Saadat M., Maraci M.R., Bagherian R.S., Mazaheri M. Comparison between the effect of liothyronine and piracetam on personal information, orientation and mental control in patients under treatment with ECT. Indian J. Psychiatry 2012, 54:154-158.
10. Grossman L., Stewart A., Gaikwad S., Utterback E., Wu N., Dileo J., Frank K., Hart P., Howard H., Kalueff A.V. Effects of piracetam on behavior and memory in adult zebrafish. Brain Res. Bull. 2011, 85:58-63.
11. Growdon J.H., Corkin S., Huff F.J., Rosen T.J. Piracetam combined with lecithin in the treatment of Alzheimer's disease. Neurobiol. Aging 1986, 7:269-276.
12. Hand T.H., Stinus L., Le Moal M. Differential mechanisms in the acquisition and expression of heroin-induced place preference. Psychopharmacology 1989, 98:61-67.
13. He Y., Wu F.X., Miao X.R., Xu X.W., Sun Y.M., Chen C.Y., Yu W.F. Suppression of acute morphine withdrawal syndrome by adenovirus-mediated beta-endorphin in rats. Brain Res. 2011, 1422:13-19.
14. Kosta P., Mehta A.K., Sharma A.K., Khanna N., Mediratta P.K., Mundhada D.R., Suke S. Effect of piracetam and vitamin E on phosphamidon-induced impairment of memory and oxidative stress in rats. Drug Chem. Toxicol. 2013, 36:48-54.
15. Kosten T.R., Morgan C., Kreek M.J. Beta endorphin levels during heroin, methadone, buprenorphine, and naloxone challenges: preliminary findings. Biol. Psychiatry 1992, 32:523-528.
16. Li S.X., Shi J., Epstein D.H., Wang X., Zhang X.L., Bao Y.P., Zhang D., Zhang X.Y., Kosten T.R., Lu L. Circadian alteration in neurobiology during 30 days of abstinence in heroin users. Biol. Psychiatry 2009, 65:905-912.
17. Liu Y. Drug treatment and rehabilitation. Annual Report on Drug Control in China 2012, 18-23. Y. Liu (Ed.).
18. Liu Y. National narcotics laboratory. Annual Report on Drug Control in China 2012, 45-47. Y. Liu (Ed.).
19. Marisco P.C., Carvalho F.B., Rosa M.M., Girardi B.A., Gutierres J.M., Jaques J.A., Salla A.P., Pimentel V.C., Schetinger M.R., Leal D.B., Mello C.F., Rubin M.A. Piracetam prevents scopolamine-induced memory impairment and decrease of NTPDase, 5'-nucleotidase and adenosine deaminase activities. Neurochem. Res. 2013, 38:1704-1714.
20. Maslov L.N., Naryzhnaia N.V., Tsibulnikov S.Y., Kolar F., Zhang Y., Wang H., Gusakova A.M., Lishmanov Y.B. Role of endogenous opioid peptides in the infarct size-limiting effect of adaptation to chronic continuous hypoxia. Life Sci. 2013, 93:373-379.
21. Niu H., Zheng Y., Huma T., Rizak J.D., Li L., Wang G., Ren H., Xu L., Yang J., Ma Y., Lei H. Lesion of olfactory epithelium attenuates expression of morphine-induced behavioral sensitization and reinstatement of drug-primed conditioned place preference in mice. Pharmacol. Biochem. Behav. 2013, 103:526-534.
22. Paxinos G., Watson C. The Rat Brain In Stereotaxic Coordinates 2005, Academic Press, New York.
23. Roth-Deri I., Green-Sadan T., Yadid G. β-Endorphin and drug-induced reward and reinforcement. Prog. Neurobiol. 2008, 86:1-21.
24. Samartgis J.R., Schachte L., Hazi A., Crowe S.F. Piracetam, an AMPAkine drug, facilitates memory consolidation in the day-old chick. Pharmacol. Biochem. Behav. 2012, 103:353-358.
25. Sharma H.S., Kiyatkin E.A. Rapid morphological brain abnormalities during acute methamphetamine intoxication in the rat: an experimental study using light and electron microscopy. J. Chem. Neuroanat. 2009, 37:18-32.
26. Shi H.S., Zhu W.L., Liu J.F., Luo Y.X., Si J.J., Wang S.J., Xue Y.X., Ding Z.B., Shi J., Lu L. PI3K/Akt signaling pathway in the basolateral amygdala mediates the rapid antidepressant-like effects of trefoil factor 3. Neuropsychopharmacology 2012, 37:2671-2683.
27. Slais K., Machalova A., Landa L., Vrskova D., Sulcova A. Could piracetam potentiate behavioural effects of psychostimulants?. Med. Hypotheses 2012, 79:216-218.
28. Stockburger C., Kurz C., Koch K.A., Eckert S.H., Leuner K., Muller W.E. Improvement of mitochondrial function and dynamics by the metabolic enhancer piracetam. Biochem. Soc. Trans. 2013, 41:1331-1334.
29. Sudai E., Croitoru O., Shaldubina A., Abraham L., Gispan I., Flaumenhaft Y., Roth-Deri I., Kinor N., Aharoni S., Ben-Tzion M., Yadid G. High cocaine dosage decreases neurogenesis in the hippocampus and impairs working memory. Addict. Biol. 2011, 16:251-260.
30. Suo L., Zhao L., Si J., Liu J., Zhu W., Chai B., Zhang Y., Feng J., Ding Z., Luo Y., Shi H., Shi J., Lu L. Predictable chronic mild stress in adolescence increases resilience in adulthood. Neuropsychopharmacology 2013, 38:1387-1400.
31. Sweep C.G., Van Ree J.M., Wiegant V.M. Characterization of beta-endorphin-immunoreactivity in limbic brain structures of rats self-administering heroin or cocaine. Neuropeptides 1988, 12:229-236.
32. Sweep C.G., Wiegant V.M., De Vry J., Van Ree J.M. Beta-endorphin in brain limbic structures as neurochemical correlate of psychic dependence on drugs. Life Sci. 1989, 44:1133-1140.
33. Tan M., Li Z., Ma S., Luo J., Xu S., Lu A., Gan W., Su P., Lin H., Li S., Lai B. Heroin activates Bim via c-Jun N-terminal kinase/c-Jun pathway to mediate neuronal apoptosis. Neuroscience 2013, 233:1-8.
34. Tzschentke T.M. Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict. Biol. 2007, 12:227-462.
35. Vernon M.W., Sorkin E.M. Piracetam. An overview of its pharmacological properties and a review of its therapeutic use in senile cognitive disorders. Drugs Aging 1991, 1:17-35.
36. Wang X., Xu H., Rothman R.B. Regulation of the rat brain endothelin system by endogenous beta-endorphin. Peptides 2006, 27:769-774.
37. Zhang M., Jing L., Liu Q., Wen R.T., Li J.X., Li Y.L., Gong Q., Liang J.H. Tramadol induces conditioned place preference in rats: interactions with morphine and buprenorphine. Neurosci. Lett. 2012, 520:87-91.